Newsroom
Abstract: In this prospective study, we assessed biomarkers of inflammation (IL-6 and SAA) from the serum of 120…
Landmark Changes Position Company for Continued Growth and Innovation Sofia, December 6, 2023 – Comac Medical, a leading…
The Bulgarian Drug Agency has announced reduced time periods for consideration of clinical trials on medicinal products for…
Comac Medical has the pleasure to inform that we will be participating in this year’s ERS International Congress…
LONDON, June 9, 2023 /PRNewswire/ — Comac Medical (Comac or the Company) announced today that funds advised by EdgeCap Partners (EdgeCap) acquired…
Some of the aspects which will be covered are: The changing spectrum of growth disorders – and the…
Comac Medical Scientific Team will take part in 25th Pharmacokinetics/Pharmacodynamics (PK/PD) Expert Meeting, Nauen (Germany), April 20th -22nd,…
We are excited to share that our Head of Biostatistics, Prof. Krassimir Kalinov, has recently contributed as an…
No more news
No more news